| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.57B | 83.73B | 83.96B | 75.63B | 70.61B | 59.51B |
| Gross Profit | 39.68B | 41.20B | 41.13B | 34.75B | 28.45B | 23.85B |
| EBITDA | 11.15B | 11.66B | 11.24B | 7.45B | 6.10B | 4.27B |
| Net Income | 6.00B | 6.74B | 6.16B | 3.71B | 2.81B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 75.80B | 82.89B | 76.17B | 75.72B | 69.79B | 60.86B |
| Cash, Cash Equivalents and Short-Term Investments | 14.43B | 16.37B | 15.45B | 17.37B | 10.49B | 8.97B |
| Total Debt | 22.07B | 23.87B | 22.94B | 28.50B | 28.85B | 23.87B |
| Total Liabilities | 42.99B | 42.78B | 43.80B | 48.33B | 47.73B | 42.14B |
| Stockholders Equity | 32.64B | 39.90B | 32.22B | 27.26B | 21.99B | 18.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.64B | 5.81B | 7.91B | -1.72B | -6.35B |
| Operating Cash Flow | 0.00 | 4.62B | 7.86B | 9.56B | 490.41M | -5.13B |
| Investing Cash Flow | 0.00 | -5.39B | -2.44B | -2.60B | -3.50B | -2.71B |
| Financing Cash Flow | 0.00 | -1.32B | -7.54B | -1.44B | 3.52B | 4.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥306.51B | 8.47 | ― | 3.08% | 18.83% | 33.06% | |
74 Outperform | ¥51.03B | 6.72 | ― | 3.07% | -0.28% | 9.21% | |
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
62 Neutral | ¥13.10B | 9.34 | ― | 4.62% | -0.44% | -13.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |